Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
XYLOBAR: Intravenous Lidocaine in Bariatric Surgery
NCT03211455Phase 3Completed
- Sponsor
- CHU Caen Normandie
- Start
- Dec 2017
- Primary completion
- Feb 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of Lidocaine Hydrochloride Injection, without epinephrine in postoperative pain, sponsored by CHU Caen Normandie. Started Dec 2017; status: completed.
02
Drugs
Lidocaine Hydrochloride Injection, without epinephrine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT03211455.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03211455.